Significance of plasma relaxin-2 levels in patients with primary hypertension and type 2 diabetes mellitus.

Published in: Wiener medizinische Wochenschrift (1946) (2024)

Decreased RLN-2 levels in patients with AH and T2DM and established relationships of RLN‑2 with SBP and parameters of glucose metabolism and lipid profile suggest a diagnostic role of RLN‑2 as a biomarker for AH with T2DM.

Keyphrases

glycemic control
blood pressure
cardiovascular risk factors
arterial hypertension